| 罗 娜,李亚妤.可诱导共刺激分子及其配体与系统性红斑狼疮的研究进展[J].浙江中西医结合杂志,2021,31(2): |
| 可诱导共刺激分子及其配体与系统性红斑狼疮的研究进展 |
| Research progress on inducible costimulatory molecules and their ligands and systemic lupus erythematosusLuo Na Li Yayu |
| 投稿时间：2020-07-12 修订日期：2020-09-13 |
| DOI： |
| 中文关键词: 可诱导共刺激分子 可诱导共刺激分子配体 系统性红斑狼疮 狼疮性肾炎 |
| 英文关键词:Inducible costimulatory molecule inducible costimulatory molecular ligands systemic lupus erythematosus lupus nephritis |
| 基金项目: |
|
| 摘要点击次数: 564 |
| 全文下载次数: 4 |
| 中文摘要: |
| 可诱导共刺激分子(ICOS)及其配体可诱导共刺激分子配体(ICOSL)是CD28/B7家族第三个成员,在系统性红斑狼疮的发生发展中发挥重要作用。近些年,ICOS/ICOSL在SLE的治疗方面的研究逐年深入,为临床SLE治疗提供了新思路。本文主要就ICOS/ICOSL与SLE关系进行概述。 |
| 英文摘要: |
| Inducible Costimulatory Molecule (ICOS) and its ligand Inducible Costimulatory Molecule Ligand (ICOSL) is the third member of the CD28/B7 family and plays an important role in the development of systemic lupus erythematosus. In recent years, ICOS/ICOSL"s research on the treatment of SLE has been deepened year by year, providing new ideas for clinical SLE treatment. This article mainly summarizes the relationship between ICOS/ICOSL and SLE. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
